The Inflation Reduction Act does lower Medicare beneficiaries’ costs by capping their out-of-pocket spending on retail drugs ...
The independent enrollment broker model should be used for full benefit dually eligible individuals for both their Medicaid ...
Fluctuations in patient volume during the COVID-19 pandemic may have been particularly concerning for rural hospitals. We examined hospital discharge data from the Healthcare Cost and Utilization ...
This past fall, ubiquitous Medicare Advantage ads on television, radio, social media, and across the internet looked a little ...
As large corporate entities and financial investors accrue more power in health care, states considering reinvigorating an ...
We propose a transparent framework for CMS to implement Medicare drug price negotiation in a manner that results in credible, ...
House-passed legislation would ban the use of quality-adjusted life-years, a metric that has gained worldwide acceptance as a ...
The COVID-19 pandemic demonstrated that US hospital and health care systems were ill-prepared for the surge of patients who ...
The A.C.C.E.S.S. AI Model is a framework for multidisciplinary stakeholders to collectively engage communities, identify ...
Repurposing a Food and Drug Administration (FDA)-approved drug for a new use has been informally practiced for years. In fact ...
On April 26, 2024, the Department of Health and Human Services published a final rule to strengthen privacy protections for ...
In their article, Philip Gruppuso, MD, and Eli Adashi, MD, MS, highlight some important inequities that necessitate the Fair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback